Dr. Eric M. Bershad, MD

Dr. Bershad practices at Baylor St. Luke's Medical Center in Houston, Texas, part of CommonSpirit Health.

Dr. Bershad's NPI, 1235109083, was assigned on January 25, 2006. Dr. Bershad graduated from Wayne State University School Of Medicine in 2002. Dr. Bershad holds Texas license M9160.

Dr. Bershad's primary practice is Baylor St. Luke's Medical Center, at 6720 Bertner Ave, STE Mc1-266, Houston, TX 77030 in Harris County. The practice phone is (832) 355-1000.

Dr. Bershad's primary practice is Baylor St. Luke's Medical Center in Houston, Texas, part of CommonSpirit Health. The medical group on file is Texas Children's Hospital. Dmand AI also links Dr. Bershad to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bershad practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Bershad's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Bershad is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bershad's licenses on file in 11 states: Texas, Florida, South Carolina, Arizona, Kentucky, North Carolina, Virginia, Georgia, Indiana, Ohio and Michigan.

Dmand AI lists cerebrovascular disease and seizures among the conditions Dr. Bershad treats.

CMS data shows 141 Medicare services from Dr. Bershad across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $17,078 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Bershad in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bershad's median patient age at 68, with 59% women.

In 2024, Dr. Bershad wrote 27 Medicare Part D claims. 96% of them were for generic drugs. They cover 3 drugs, with $848 in total drug cost. In 2019, CMS named 76 claims across 3 drugs.

Dr. Bershad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 52 papers to Dr. Bershad, published from 2011 to 2022. 2013 was the busiest year, with 5. The most frequent topics are Cerebral Hemorrhage, Head-Down Tilt and Intracranial Pressure. Dr. Bershad has published most often in Neurocrit Care. Dr. Bershad's most frequent co-authors are Chethan Padavanapalli Venkatasubba Rao, MD, Jose I. Suarez, MD and Rahul Damani, MD.

CMS Open Payments shows 1 general payment to Dr. Bershad from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $68.

Dr. Bershad graduated from Wayne State University School Of Medicine in 2002.

Dr. Bershad is in network with 18 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.